ATORX — Alligator Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK105.65m
- SEK105.06m
- SEK0.51m
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln
Brief: Alligator Bioscience Gets Patent In United States
Sweden's Alligator Bioscience Q4 net loss widens
Brief: Alligator Bioscience Q4 EBIT SEK -22.5 Million
Brief: Alligator Bioscience Resolves On Directed Issue Of 18,585,000 Units
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience Announces Prelim Outcome Of Rights Issue
Brief: Alligator Bioscience Receives Additional Subscription Undertakings For Rights Issue
Brief: Alligator Bioscience Announces Final Terms Of Rights Issue
Brief: Alligator Bioscience Gets US Patent Covering Ator-4066 Bispecific Antibody
Brief: Alligator Announces Final 30-Month Optimize-1 Results
Brief: Alligator Bioscience To Receive Approximately SEK 28.1 Mln From Warrants
Brief: Alligator Bioscience: Preliminary Outcome Of Exercise Of Warrants Series TO 13
Brief: Alligator Bioscience, Fenja Agree On Extension Of Loan Maturity
Brief: Alligator Bioscience: Grant Awarded To Phase 2/3 Trial With Mitazalimab In Biliary Tract Cancer
Brief: Alligator Bioscience Q2 Operating Loss Lowers To SEK 22.3 Mln